has been cited by the following article(s):
|
[1]
|
Patents involving monoamine oxidase (MAO): a comprehensive update (2022–2025) on its inhibitors and applications
Expert Opinion on Therapeutic Patents,
2026
DOI:10.1080/13543776.2026.2633345
|
|
|
|
|
[2]
|
Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition)
2022
DOI:10.2174/9789815040913122010015
|
|
|
|